17 DECEMBER, 2020
Podcast: Unlocking the Gut Health “Black Box” with Atmo Biosciences
Our CEO Malcolm Hebblewhite recently chatted with Theresa “Sam” Houghton of The Modern Health Nerd podcast about how Atmo is shining a light on the mysteries of the human gut, and what that could mean for the millions of people who suffer from gut disorders like IBS and IBD.
Listen to the discussion below or search for “The Modern Health Nerd” on Apple Podcasts, Overcast or Spotify.
READ MORE
14 OCTOBER, 2020
Atmo CEO Mal Hebblewhite interviewed on ausbiz
Atmo CEO Malcolm Hebblewhite was interviewed live in the ausbiz studio about how Atmo Biosciences can improve diagnosis and management of gastrointestinal disorders.
READ MORE
20 JULY, 2020
Atmo Biosciences wins $620K grant to advance commercialization of ingestible gas-sensing capsule to diagnose gut disorders
Atmo Biosciences has been awarded a $620,000 Australian Government grant through the BioMedTech Horizons (BMTH) program.
READ MORE
2 JUNE, 2020
Atmo Biosciences raises $2.5m in seed financing
Atmo Biosciences has raised a further A$2.5 million in an oversubscribed funding round, supplementing an initial seed raise in March 2019.
READ MORE
